Pharmaceutical Grade 3-Chloropropyl Dibutylamine Specifications: Quality Assurance for API Synthesis
- Meets ≥98% industrial purity standard with full Certificate of Analysis (COA) for pharmaceutical use
- Serves as a critical chemical intermediate in the synthesis of dronedarone hydrochloride, an antiarrhythmic API
- Manufactured under strict ICH Q7 and GMP-aligned protocols with traceable impurity profiling
In the development of high-potency active pharmaceutical ingredients (APIs), the quality of intermediates directly dictates final drug safety and efficacy. N-(3-chloropropyl)dibutylamine (CAS 36421-15-5), also systematically named N-butyl-N-(3-chloropropyl)butan-1-amine, is a pivotal building block in the synthesis of dronedarone—a Class III antiarrhythmic agent used to manage atrial fibrillation. As a pharmaceutical intermediate, its specification profile must adhere to stringent chemical and regulatory benchmarks to ensure batch-to-batch consistency and minimal genotoxic impurities.
Critical Quality Attributes (CQAs) for Pharmaceutical-Grade Material
Pharmaceutical-grade N,N-dibutyl-3-chloro-1-propanamine must satisfy multiple critical quality attributes beyond simple assay percentage. These include:
- Purity ≥98%: Verified by GC or HPLC against calibrated standards
- Residual solvent limits: Compliant with ICH Q3C guidelines (e.g., chloroform, dichloromethane)
- Heavy metals: ≤10 ppm (as per USP <231> or Ph. Eur. 2.4.8)
- Water content: Typically ≤0.5% by Karl Fischer titration
- Color and appearance: Pale yellow, clear liquid—free from particulates
When sourcing high-purity N-(3-chloropropyl)dibutylamine, buyers should verify that the supplier provides a comprehensive Certificate of Analysis (COA) detailing all above parameters alongside spectral data (¹H NMR, ¹³C NMR, HRMS).
Synthesis Route and Process Control
The industrial manufacturing process for dibutyl(3-chloropropyl)amine typically involves the chlorination of 3-(dibutylamino)propan-1-ol using thionyl chloride (SOCl₂). A well-optimized route achieves >94% isolated yield while minimizing side products such as elimination derivatives or over-chlorinated species. Key process controls include:
- Strict temperature regulation during exothermic chlorination
- Inert atmosphere (N₂ or Ar) to prevent oxidation
- Controlled stoichiometry to limit residual SOCl₂ and HCl
- Efficient workup with potassium carbonate and sequential aqueous washes
This synthesis route ensures high reproducibility and scalability—essential for bulk production of API intermediates. The resulting product, 3-chloropropyl dibutylamine, exhibits a boiling point of 118–130 °C at 25 Torr and a predicted density of 0.899 ± 0.06 g/cm³, consistent with literature values.
Regulatory Compliance and Analytical Validation
As a dronedarone intermediate, this compound falls under ICH Q11 guidance for the development and manufacture of drug substances. Regulatory submissions require robust analytical methods for impurity profiling. Common techniques include:
| Parameter | Method | Acceptance Criteria |
|---|---|---|
| Assay Purity | GC-FID or HPLC-UV | ≥98.0% |
| Related Substances | HPLC-DAD/MS | Any single impurity ≤0.3%; total impurities ≤1.0% |
| Residual Solvents | GC-Headspace | Class 2 solvents within ICH Q3C limits |
| Elemental Impurities | ICP-MS | Compliant with ICH Q3D (e.g., Cd, Pb, As ≤5 ppm) |
These methods are validated per ICH Q2(R1) for specificity, accuracy, precision, linearity, and robustness—ensuring reliable detection of potential genotoxic impurities like alkyl chlorides or amine degradation products.
Bulk Procurement and Industrial Supply Chain
For contract development and manufacturing organizations (CDMOs) and generic API producers, access to a reliable global manufacturer of high-purity N-(3-chloropropyl)dibutylamine is essential. Leading suppliers offer multi-ton monthly capacity with flexible packaging (from 100g lab scale to 200L drums) and full regulatory documentation (DMF support, GMP audit readiness).
Current market trends indicate stable bulk pricing around $50/kg for ≥99% purity material at kilogram scale, with volume discounts available for multi-kilogram or tonnage orders. Crucially, reputable vendors maintain strict cold-chain logistics (storage at 2–8 °C) to preserve stability, given the compound’s susceptibility to hydrolysis and amine oxidation over time.
Conclusion
Pharmaceutical-grade N-(3-chloropropyl)dibutylamine demands more than just high assay—it requires end-to-end quality control from synthesis to shipment. With its role as a key chemical intermediate in life-saving cardiovascular therapeutics, only suppliers with proven expertise in fine chemical manufacturing and regulatory compliance should be considered. For technical data, COA samples, or bulk quotations, qualified buyers are encouraged to engage directly with certified producers who prioritize reaction yield integrity, industrial purity, and global supply reliability.